Dr. Christopher Lee Amling, FACS, MD

Dr. Amling practices at OHSU Hospital in Portland, Oregon, part of State of Oregon.

Dr. Amling's NPI, 1134173032, was assigned on May 22, 2006. Dr. Amling graduated from OHSU School of Medicine in 1985. Dr. Amling's Oregon license number on file is MD29001.

Dr. Amling's primary practice is OHSU Hospital, at 3181 SW Sam Jackson Park Road, Portland, OR 97239 in Multnomah County. The practice phone is (503) 494-9000.

Dr. Amling's primary practice is OHSU Hospital in Portland, Oregon, part of State of Oregon. Dr. Amling is also affiliated with Adventist Health Portland. The medical group on file is Oregon Health & Science University (OHSU). Dmand AI also links Dr. Amling to 1 more hospital and 1 clinical lab, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Amling practices, 4 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Amling's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Amling is board certified in urology by the American Board of Urology. Dmand AI has Dr. Amling's licenses on file in 6 states: Oregon, California, Alabama, North Carolina, Minnesota and Hawaii.

Dmand AI lists bladder removal, enlarged prostate, enlarged prostate transurethral surgery (TURP), kidney removal surgery, prostate inflammation or infection, prostate surgery and urinary endoscopy among the conditions Dr. Amling treats.

CMS data shows 390 Medicare services from Dr. Amling across 13 procedure codes in 2024, for 164 Medicare patients. Medicare paid $44,422 for them.

CMS counts 164 Medicare patients who saw Dr. Amling in 2024. The largest group is 65 to 74, with 98 patients. 75% of them have cancer, and 68% have high cholesterol. Their average risk score is 1.01, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Amling's median patient age at 74, with 5% women.

In 2024, Dr. Amling wrote 13 Medicare Part D claims. 100% of them were for generic drugs. They cover 2 drugs, with $539 in total drug cost. In 2017, CMS named 132 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Amling for performance year 2024, reported through an alternative payment model (APM). Dr. Amling accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Amling as offering telehealth. CMS counts 30 procedures of prostate resection by Dr. Amling, more than 91% of the clinicians it reports for that procedure.

Dmand AI links 84 papers to Dr. Amling, published from 2003 to 2024. 2019 was the busiest year, with 6. The most frequent topics are Prostatic Neoplasms, Prostatectomy and Prostate-Specific Antigen. Dr. Amling has published most often in J Urol. Dr. Amling's most frequent co-authors are John P. Foley, MD, Bryan Robert Foster, MD and Christopher J. Kane, MD.

CMS Open Payments shows 29 general payments to Dr. Amling from 9 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 44% of the total. Intuitive Surgical, Inc. paid the most, $10,162.

Dmand AI lists 9 awards for Dr. Amling, most recently America's Top Doctors in 2015.

Dr. Amling graduated from OHSU School of Medicine in 1985. Dr. Amling is a member of ACS.

Dr. Amling is in network with 17 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.